<p>Panels A and C show IFN-γ production upon stimulation with the Pol peptide pool (A) and an individual Pol peptide (C). Panels B and D are gated on the IFN-γ producing cells and show differentiation phenotype of these HIV-1 specific cells as defined by CCR7 and CD45RA isoform. The terminally differentiated response to the Pol peptide 356–374 (31.9% CCR7−/CD45RA+ of gated cells) is diluted in the response to the entire Pol peptide pool (only 8.8% gated cells are CCR7−/CD45RA+).</p
<p>(a) The frequency of CD8<sup>+</sup> IFN-γ<sup>+</sup> Gr-B<sup>+</sup> CD107a<sup>+</sup> detect...
<p>A) Percentage of individuals making responses from either group: solid bars indicate the viremic ...
<p>ICS was performed on a subset of samples from Groups 1–3, at baseline, visits 07/08 (2–4 weeks po...
<p>(a) The frequency of terminally differentiated effector (CD8<sup>+</sup> IFN-γ<sup>+</sup> CD45RA...
Peptide-specific IFNγ-producing T cell responses to administrations of MVA, αDCIR.HIV5pep and αCD40....
<p>(A) Mapping of epitopes was done using pools of overlapping peptides. The peptides spanned the en...
<p>and CD8<sup>+</sup> T cells. CD4<sup>+</sup> (open boxes) and CD8<sup>+</sup> (shaded boxes) T ce...
<p>(A) Percentage of CD45RA+/CCR7−/CD8+ T cells for the 126 and 106 HIV-1-specific CD8+ T cell respo...
<p>IFN-γ ELISPOT assay was performed to evaluate T-cell responses against the 27 M-group consensus p...
<p>PBMCs from clade B HIV-infected individuals were screened for responses to (a) pools of HLA-Cw*01...
<p>The HIV<sub>CONSV</sub>-specific memory T cells were assessed in healthy and HIV-1-infected subje...
<p><b>A.</b> PHI patients: frequency of CD4+ T-cells producing at least one cytokine (IFN-γ, MIP-1β ...
<p>The peptides sets evaluated were dictated by availability from the NIH AIDS reagent programme; cl...
PBMCs were collected from individual animals at week 10 (two weeks post MVA) and at peak response ti...
<p>(A) To evaluate T cell response breadth, PBMC from different patient groups were stimulated with ...
<p>(a) The frequency of CD8<sup>+</sup> IFN-γ<sup>+</sup> Gr-B<sup>+</sup> CD107a<sup>+</sup> detect...
<p>A) Percentage of individuals making responses from either group: solid bars indicate the viremic ...
<p>ICS was performed on a subset of samples from Groups 1–3, at baseline, visits 07/08 (2–4 weeks po...
<p>(a) The frequency of terminally differentiated effector (CD8<sup>+</sup> IFN-γ<sup>+</sup> CD45RA...
Peptide-specific IFNγ-producing T cell responses to administrations of MVA, αDCIR.HIV5pep and αCD40....
<p>(A) Mapping of epitopes was done using pools of overlapping peptides. The peptides spanned the en...
<p>and CD8<sup>+</sup> T cells. CD4<sup>+</sup> (open boxes) and CD8<sup>+</sup> (shaded boxes) T ce...
<p>(A) Percentage of CD45RA+/CCR7−/CD8+ T cells for the 126 and 106 HIV-1-specific CD8+ T cell respo...
<p>IFN-γ ELISPOT assay was performed to evaluate T-cell responses against the 27 M-group consensus p...
<p>PBMCs from clade B HIV-infected individuals were screened for responses to (a) pools of HLA-Cw*01...
<p>The HIV<sub>CONSV</sub>-specific memory T cells were assessed in healthy and HIV-1-infected subje...
<p><b>A.</b> PHI patients: frequency of CD4+ T-cells producing at least one cytokine (IFN-γ, MIP-1β ...
<p>The peptides sets evaluated were dictated by availability from the NIH AIDS reagent programme; cl...
PBMCs were collected from individual animals at week 10 (two weeks post MVA) and at peak response ti...
<p>(A) To evaluate T cell response breadth, PBMC from different patient groups were stimulated with ...
<p>(a) The frequency of CD8<sup>+</sup> IFN-γ<sup>+</sup> Gr-B<sup>+</sup> CD107a<sup>+</sup> detect...
<p>A) Percentage of individuals making responses from either group: solid bars indicate the viremic ...
<p>ICS was performed on a subset of samples from Groups 1–3, at baseline, visits 07/08 (2–4 weeks po...